Last updated: August 27, 2013
Sponsor: Hebei Medical University
Overall Status: Completed
Phase
3
Condition
Heart Failure
Chest Pain
Congestive Heart Failure
Treatment
N/AClinical Study ID
NCT01559727
GL-2011-29
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
hospitalized for symptomatic heart failure
dyspnea at rest or with minimal activity
NT-proBNP > 1000pg/ml
LVEF ≤ 40%
Exclusion
Exclusion Criteria:
any condition (other than CHF) that could limit the use of prednisone;
acute decompensated heart failure
active myocarditis
obstructive or restrictive cardiomyopathy
cardiac surgery within previous 3 months
acute coronary syndrome
Study Design
Total Participants: 40
Study Start date:
March 01, 2012
Estimated Completion Date:
March 31, 2013
Study Description
Connect with a study center
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei 050031
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.